Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2020

Jun 17, 2020

31873_dirs_2020-06-17_5af6a74a-18bc-45bf-8da2-7a870e3495a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-06-16

Reporting Person: Daniels Mark (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-16 Common Stock M 3536 $5.95 Acquired 57254 Direct
2020-06-16 Common Stock S 3536 $38.7956 Disposed 53718 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-16 Employee Stock Option (right to buy) $5.95 M 3536 Disposed 2026-08-29 Common Stock (3536) Direct

Footnotes

F1: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.75 to $38.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F2: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.